NCT06822426 - Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC) | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

Central Line Associated Blood Stream Infections (CLABSI)

Interventions

DRUG

(taurolidine and heparin) catheter lock solution

for central venous catheter installation use

DRUG

Heparin

Trial Locations (11)

10032

NOT_YET_RECRUITING

Columbia University Irving Medical Center, New York

19104

RECRUITING

Hospital of the University of Pennsylvania, Philadelphia

21205

RECRUITING

Johns Hopkins Clinical Research Unit, Baltimore

27710

RECRUITING

Duke University Hospital, Durham

30322

RECRUITING

Emory University Hospital - GCRC, Atlanta

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

52242

RECRUITING

University of Iowa Health Care, Iowa City

55905

RECRUITING

Mayo Clinic, Rochester

68198-3285

RECRUITING

University of Nebraska Medical Center, Omaha

02903

RECRUITING

Rhode Island Hospital, Providence

37212-1150

RECRUITING

Vanderbilt Center for Human Nutrition, Nashville